Experience

• • Due to the sensitive nature of Mr. Rubin’s confidential work counseling companies on FDA/FTC compliance matters, and handling non-public investigations, only a portion of his representative matters can be publicly disclosed.

• Mergers & Acquisitions –Regulatory Due Diligence

  • Covetrus, a global animal health and technology and services company and a CD&R and TPG portfolio company, in its merger with MWI Animal Health, a global provider of animal health products, valuing MWI at $3.5 billion.
  • Arctic Glacier, a provider of premium ice products and services and Carlyle portfolio company, in its sale to Reddy Ice, a manufacturer and distributor of packaged ice.
  • CD&R and Drive DeVilbiss Healthcare, a global manufacturer of medical products, in the sale of Drive to Kingswood Capital Management.
  • KKR in its acquisition of a majority ownership stake in HealthCare Royalty Partners, a leading biopharma royalty acquisition company.
  • Tractor Supply Company in its acquisition of Allivet, an online pet pharmacy.
  • S&S Activewear, a tech-enabled provider of apparel and accessories, and its majority owner Clayton, Dubilier & Rice, in S&S Activewear’s acquisition of alphabroder, distributor of trade, retail, apparel brands and branded products.
  • Sawai and Sumitomo in the $210 million sale of its subsidiary Upsher-Smith Laboratories to Bora Pharmaceuticals.
  • Clayton, Dubilier & Rice in its acquisition of Shearer’s Foods, a leading contract manufacturer and private label supplier in the snack industry in North America.
  • Gedeon Richter, the specialty pharmaceutical company, in its acquisition of OC Distributors, an Ireland-based company holding the marketing and distribution rights of a number of women’s healthcare products.
  • Inovar Packaging Group, a Kelso & Company portfolio company, in its acquisition of Cimarron Label and Western Printing, a label printing provider.
  • Kelso & Company and its portfolio company, Eagle Family Foods Group, in their acquisition of General Mills’ Helper main meals and Suddenly Salad side dishes businesses, in a transaction valued at approximately $610 million.
  • Clayton, Dubilier & Rice and TPG in their $4 billion take-private of Covetrus, a global animal-health technology and services company.
  • Morgan Stanley Capital Partners in its acquisition of Fairway Lawns, a residential lawncare services provider.
  • Resonetics, a Carlyle portfolio company and a leader in micro-manufacturing for the medical device and diagnostics equipment, in its acquisition of EaglePicher Medical Power, a medical device manufacturer.
  • Blackstone as lead investor in DNAnexus’ $200 million financing round.
  • Carlyle in its strategic partnership with Orsini, an independent specialty pharmacy focused on rare diseases, gene therapies and complex conditions.
  • Carestream Dental, a Clayton, Dubilier & Rice portfolio company and leading provider of dental technology, in the $600 million carve-out sale of its Scanning Technology business to Envista, a leading global dental products company.
  • Carlyle in its investment in Resonetics, a leader in micro-manufacturing for the medical device and diagnostics equipment industries, valuing the company at approximately $2.25 billion.
  • Carlyle in its acquisition of a majority stake in Saama, a leading AI-driven intelligent clinical cloud company that enables the life sciences industry to conduct faster and safer clinical developments and regulatory programs.
  • Blackstone in its investment in Medable, the leading cloud platform for patient-centered clinical research, valuing Medable at $2.1 billion.
  • Pactiv Evergreen in its $380 million acquisition of Fabri-Kal, a U.S. manufacturer of foodservice and custom thermoformed plastic packaging solutions.
  • Clayton, Dubilier & Rice in its $6 billion acquisition and subsequent combination of Fort Dearborn and Multi-Color Corporation, to create the world's largest label solutions company.
  • Kelso & Company in its acquisition of Ferraro Foods, a specialty foodservice distributor.
  • Blackstone in its investment in Ginger, a leader in on-demand behavioral healthcare.
  • CPP Investments as lead investor in a $400 million Series C financing for insitro, a machine learning-driven drug discovery and development company.
  • Morgan Stanley Capital Partners in the sale of Manna Pro Products, a recognized leader in pet care, to Carlyle.
  • TPG in the sale of Adare Pharmaceuticals, a leading specialty contract development and manufacturing organization, to Thomas H. Lee Partners and Frazier Healthcare Partners and the related separation of Adare’s Eosinophilic Esophagitis product into a TPG-backed entity.
  • Johnson & Johnson in its acquisition of TARIS, a biotechnology company specializing in the development of a novel drugs and delivery technologies for the treatment of cancer.
  • Allergan in its sale of Brazikumab to AstraZeneca and Zenpep to Nestle.
  • Prudential Financial in its $2.35 billion acquisition of Assurance IQ, a direct-to-consumer platform that transforms the buying experience for individuals seeking personalized health and financial wellness solutions.
  • Manna Pro, a manufacturer and marketer of pet care and nutrition products and a Morgan Stanley Capital Partners portfolio company, in its acquisition of Hero Pet Brands.
  • CPP Investments in the $700 million growth equity financing of Sana Biotechnology, a U.S.-based biotech company focused on creating and delivering engineered cells as treatments for disease.

• FDA/FTC Compliance Matters

  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the $600 million sale of its subsidiary, Ambry Genetics, to Tempus AI.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the sale of its subsidiary Invicro to Calyx, a portfolio company of CapVest and leading technology-enabled provider.
  • Clayton, Dubilier & Rice and Sharp in Sharp’s acquisition of Berkshire Sterile Manufacturing.
  • RentGrow Inc., a background screening company, and its parent company Yardi in an investigation by the CFPB and the FTC, and settlement with the FTC, relating to the Fair Credit Reporting Act and the FTC Act.
  • Numerous FDA and non-FDA regulated companies in confidential investigations.
  • A leading marketing company in settling advertising allegations with the FTC.
  • Numerous pharmaceutical, medical device, and consumer product companies in addressing complex FDA compliance issues.
  • Numerous investment banks and financial services companies in various hemp and CBD regulatory issues.
  • Medical Device Innovation Consortium, in preparing a comprehensive “cybersecurity playbook” for the medical device industry.